That will not happen here.
The buyers have formed a private company and would need to do an IPO of their own shares before they could swap with BIOA.
LCY parent trades on Taiwan market.
IMO, they might possibly reverse merge into the BIOA shell in order to get shares trading on TSX and NYSE in a very short period of time. That means they MUST get the share price back over $2 minimum, maybe $3.
Once they have full control, they can authorize more shares, share classes, change the O/S... and basically do whatever they want.
Fun, huh? :-)